Clinical cases are those in which infection is present, compared to screening cases, which refer to cases where the fungus is detected and has colonized but has not led to infection.
Health agencies consider C. auris among the pathogens that pose the greatest threat to public health because of its ability to spread quickly in healthcare settings and cause severe infections among immunocompromised people. The U.S. saw its first clinical case in 2016. Between 2020 and 2021, cases grew 95%. Read more about C. auris here.
Below is a list of the number of clinical cases reported in the U.S. in 2022, based on CDC data. A total of 2,377 cases were reported in 22 states and Washington, D.C:
Nevada: 384 clinical cases
California: 359
Florida: 349
New York: 326
Illinois: 276
Texas: 160
New Jersey: 94
Indiana: 87
Ohio: 79
Maryland: 46
Virginia: 40
Michigan: 33
Pennsylvania: 33
Kentucky: 22
District of Columbia: 19
Arizona: 17
Georgia: 12
Louisiana: 10
Tennessee: 8
Alabama: 6
Delaware: 5
Mississippi: 5
Massachusetts: 2
Colorado: 1
Hawaii: 1
Minnesota: 1
New Mexico: 1
Wisconsin: 1
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.